4//SEC Filing
Kalin Katherine Bach 4
Accession 0001104659-23-010613
CIK 0001390478other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:10 PM ET
Size
7.6 KB
Accession
0001104659-23-010613
Insider Transaction Report
Form 4
Kalin Katherine Bach
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-02-02+9,500→ 9,500 totalExercise: $3.34Exp: 2033-02-02→ Common Stock (9,500 underlying) - Award
Common Stock
2023-02-02+2,500→ 2,500 total
Footnotes (2)
- [F1]The Reporting Person received an award of 2,500 restricted stock units on February 2, 2023, which shall vest in full on December 1, 2023, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
- [F2]The shares subject to the option will fully vest on the earlier of (x) February 2, 2024 (the first anniversary of the date of grant) or (y) the business day prior to the 2024 annual stockholders meeting, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such date.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001832671
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:10 PM ET
- Size
- 7.6 KB